|
|
||||||||
The FASEB Journal, Vol 4, 215-221, Copyright © 1990 by The Federation of American Societies for Experimental Biology
RESEARCH COMMUNICATIONS |
J Armendariz-Borunda, JM Seyer, AH Kang and R Raghow
Veterans Administration Medical Center, Memphis, Tennessee 38104.
Transforming growth factor beta (TGF beta) has been implicated as having a central role in the postinflammatory tissue regeneration and fibrosis. To test its potential involvement in events that follow hepatotoxin-mediated liver regeneration and fibrosis, we quantitated changes in the steady-state levels of TGF beta mRNA in parenchymal and nonparenchymal cells at various times after an acute treatment with CCl4, and also compared TGF beta gene expression in these two cell types from livers subjected to chronic CCl4 treatment. The parenchymal and nonparenchymal cells from normal liver contained undetectable amounts of TGF beta mRNA. In contrast, we could readily detect TGF beta specific transcripts in both the parenchymal and nonparenchymal cells after acute injury. Nonparenchymal cells from acutely injured liver contained fivefold greater amounts of TGF beta mRNA, which peaked at 48 h and declined thereafter. In chronically treated rat livers (1, 2, 3, and 7 wk after the initiation of CCl4 treatment), increased expression of TGF beta mRNA was found only in nonparenchymal cells obtained after 2-3 wk of treatment. Strikingly large elevations in the steady-state levels of beta-actin mRNA in CCl4-treated liver were also observed, which may be related to the known regenerative processes associated with acute liver toxicity. Changing dynamics of TGF beta gene expression, therefore, appear to be an important attribute of regenerating liver after acute or chronic CCl4 toxicity.
This article has been cited by other articles:
![]() |
H.-N. Chen, S. Fan, and C.-F. Weng Down-regulation of TGF{beta}1 and leptin ameliorates thioacetamide-induced liver injury in lipopolysaccharide-primed rats Innate Immunity, June 1, 2007; 13(3): 176 - 188. [Abstract] [PDF] |
||||
![]() |
E. J. Mullin, M. S. Metcalfe, and G. J. Maddern Artificial Liver Support: Potential to Retard Regeneration? Arch Surg, June 1, 2004; 139(6): 670 - 677. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pan, M. Clayton, and M. A. Feitelson Hepatitis B virus X antigen promotes transforming growth factor-{beta}1 (TGF-{beta}1) activity by up-regulation of TGF-{beta}1 and down-regulation of {alpha}2-macroglobulin J. Gen. Virol., February 1, 2004; 85(2): 275 - 282. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Date, K Matsuzaki, M Matsushita, Y Tahashi, F Furukawa, and K Inoue Modulation of transforming growth factor beta function in hepatocytes and hepatic stellate cells in rat liver injury Gut, May 1, 2000; 46(5): 719 - 724. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Shi, A. E. Wakil, and D. C. Rockey Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses PNAS, September 30, 1997; 94(20): 10663 - 10668. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Anscher, W. P. Peters, H. Reisenbichler, W. P. Petros, and R. L. Jirtle Transforming Growth Factor {beta} as a Predictor of Liver and Lung Fibrosis after Autologous Bone Marrow Transplantation for Advanced Breast Cancer N. Engl. J. Med., June 3, 1993; 328(22): 1592 - 1598. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |